1.
Rev Peru Med Exp Salud Publica
; 40(3): 377-378, 2023.
Artigo
em Espanhol, Inglês
| MEDLINE
| ID: mdl-37991045
2.
Rev. peru. med. exp. salud publica
; 40(3)jul. 2023.
Artigo
em Espanhol
| LILACS, INS-PERU
| ID: biblio-1522784
3.
New Microbes New Infect
; 51: 101082, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36873288
RESUMO
The presence of crpP was established in 201 Pseudomonas aeruginosa isolates from 9 Peruvian hospitals. The 76.6% (154/201) of the isolates presented the crpP gene. Overall, 123/201 (61.2%) isolates were non-susceptible to ciprofloxacin. The prevalence of crpP-possessing P. aeruginosa in Peru is higher than in other geographical areas.